Megtrli 1mg Injection
Marketer
Ridhima Biocare
Salt Composition
Terlipressin (1mg)
Overview Megtrli 1mg Injection
Octreotide acetate 1mg injection treats life-threatening bleeding from enlarged esophageal veins. It constricts blood vessels, reducing blood flow to affected areas. Administration is strictly by a healthcare professional; self-injection is prohibited. Dosage and frequency are determined solely by your physician, reserved for patients with severe esophageal hemorrhage. Potential side effects include headache, bradycardia, hypertension, peripheral vasoconstriction, and peripheral ischemia or hypotension. Report persistent or worsening side effects. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications. This injection is unsuitable for pediatric use.
Primary Ingredients of Megtrli 1mg Injection
No information provided. Unable to rephrase.
Uses of Megtrli 1mg Injection
Hemorrhage from esophageal varices
Major Benefits of Megtrli 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megtrli 1mg Injection:
- Headache
- Slow heart rate
- Abdominal cramp
- Diarrhea
- High blood pressure
- Peripheral ischemia
- Vasoconstriction of the extremities
How to use Megtrli 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megtrli 1mg Injection works:
Megtrli 1mg Injection constricts blood vessel walls, reducing blood flow to affected veins, thereby controlling or arresting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Megtrli 1mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyUNSAFE
Administering Megtrli 1mg Injection during pregnancy presents a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies has revealed considerable adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Megtrli 1mg Injection with breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Megtrli 1mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Megtrli 1mg Injection's use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Megtrli 1mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Megtrli 1mg Injection :
Omit any missed dose of Megtrli 1mg Injection and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Megtrli 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Synthetic vasopressin |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | Synthetic vasopressin |
3,018 People bought this recently